Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of hepatitis B surface antigen in patients with ankylosing spondylitis and its association with HLA-B27: a retrospective study from south China

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To investigate the prevalence of hepatitis B surface antigen (HBsAg), a seromarker for current infection of hepatitis B virus, in patients with ankylosing spondylitis (AS) from south China and to evaluate its association with human leukocyte antigen (HLA)-B27. The prevalence of HBsAg was retrospectively investigated in 439 patients with AS, 606 age- and sex-matched general individuals, 172 patients with other spondyloarthropathy (SpA), 698 patients with rheumatoid arthritis (RA), and 220 patients with osteoarthritis (OA). The positive rate of HBsAg in AS group was compared with those of the general population group and other disease groups, respectively, and the prevalence of HBsAg was compared between HLA-B27-positive and HLA-B27-negative patients with AS. The positive rate of HBsAg in AS patients, general population, other-SpA, RA, and OA patients were 25.39, 12.87, 14.53, 9.60, and 8.18%, respectively. The HBsAg prevalence of AS group was statistically higher than those of any other groups (P < 0.05). The prevalence of HBsAg in HLA-B27-positive and HLA-B27-negative AS patients were 26.68 and 14.49%, respectively, the positive rate of HBsAg in HLA-B27-positive AS patients was statistically higher than that of HLA-B27-negative AS patients (P < 0.05). The prevalence of HBsAg in AS patients was higher than those in general population, patients with other-SpA, RA, and OA. The high HBsAg prevalence in AS patients might be associated with their high frequency of HLA-B27 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 301:904–907

    Article  Google Scholar 

  2. Domínguez-López ML, Ortega-Ortega Y, Manríquez-Raya JC, Burgos-Vargas R, Vega-López A, García-Latorre E (2009) Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients. Clin Exp Rheumatol 27:626–632

    PubMed  Google Scholar 

  3. McMichael A, Bowness P (2002) HLA-B27: natural function and pathogenic role in spondyloarthritis. Arthritis Res 4(Suppl 3):S153–S158

    Article  PubMed  Google Scholar 

  4. Gaston JS (2001) Infection in the aetiology of spondyloarthropathies. Clin Med 1:104–107

    PubMed  CAS  Google Scholar 

  5. Rashid T, Ebringer A (2007) Ankylosing spondylitis is linked to Klebsiella–the evidence. Clin Rheumatol 26:858–864

    Article  PubMed  Google Scholar 

  6. Girschick HJ, Guilherme L, Inman RD et al (2008) Bacterial triggers and autoimmune rheumatic diseases. Clin Exp Rheumatol 26(Suppl 48):S12–S17

    PubMed  CAS  Google Scholar 

  7. Kim TH, Uhm WS, Inman RD (2005) Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumato 17:400–405

    Article  Google Scholar 

  8. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112–125

    Article  PubMed  Google Scholar 

  9. Nojima T, Hirakata M, Sato S et al (2000) A case of polymyositis associated with hepatitis B infection. Clin Exp Rheumatol 18:86–88

    PubMed  CAS  Google Scholar 

  10. Janssen HL, van Zonneveld M, van Nunen AB, Niesters HG, Schalm SW, de Man RA (2004) Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. Eur J Gastroenterol Hepatol 16:801–807

    Article  PubMed  CAS  Google Scholar 

  11. Zhao J, Qiu M, Li M, Lu C, Gu J (2010) Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. Rheumatol Int 30:1565–1570

    Article  PubMed  Google Scholar 

  12. Csepregi A, Nemesanszky E, Rojkovich B, Poor G (2001) Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link. J Rheumatol 28:474–477

    PubMed  CAS  Google Scholar 

  13. Tanasescu C, Parvu M, Antohi I, Lazar S (1999) The significance of chronic hepatitis B and C virus infections in some connective tissue diseases: the association with chronic liver disease. Rom J Intern Med 37:53–64

    PubMed  CAS  Google Scholar 

  14. Aksu K, Kabasakal Y, Sayiner A et al (1999) Prevalences of hepatitis A, B, C and E viruses in Behcet’s disease. Rheumatology (Oxford) 38:1279–1281

    Article  CAS  Google Scholar 

  15. Guillevin L, Mahr A, Callard P et al (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84:313–322

    Article  Google Scholar 

  16. Solís-Herruzo JA, Muñoz-Yagüe T (2003) Polyarteritis nodosa and hepatitis B virus infection. Rev Esp Enferm Dig 95:155–156

    Google Scholar 

  17. den Uyl D, van der Horst-Bruinsma IE, van Agtmael M (2004) Progression of HIV to AIDS: a protective role for HLA-B27? AIDS Rev 6:89–96

    Google Scholar 

  18. Neumann-Haefelin C, McKiernan S, Ward S et al (2006) Dominant influence of an HLA-B27 restricted CD8 + T cell response in mediating HCV clearance and evolution. Hepatology 43:563–572

    Article  PubMed  CAS  Google Scholar 

  19. Hu DB, Liu SK, Zhao LL, Xu AP, Hong YZ, Cao PY (2009) Analysis the relation of adults HBV vicinal failure and T cell subset, HLA-DR rang gene phenotype. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23(1):17–19

    PubMed  CAS  Google Scholar 

  20. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  21. Maya R, Gershwin ME, Shoenfeld Y (2008) Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 34:85–102

    Article  PubMed  Google Scholar 

  22. Zizer E, Hasel C, Seufferlein T, Adler G, Dikopoulos N (2008) A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection. Z Gastroenterol 46:201–205

    Article  PubMed  CAS  Google Scholar 

  23. Gwak GY, Koh KC, Kim HY (2007) Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate. Clin Exp Rheumatol 25:888–889

    PubMed  Google Scholar 

  24. Liang XF, Chen YS, Wang XJ et al (2005) A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years-old. Zhonghua Liu Xing Bing Xue Za Zhi 26:655–658

    PubMed  Google Scholar 

  25. Elavia AJ, Banker DD (1991) Prevalence of hepatitis B surface antigen and its subtypes in high risk group subjects and voluntary blood donors in Bombay. Indian J Med Res 93:280–285

    PubMed  CAS  Google Scholar 

  26. Song BC, Kim SH, Kim H et al (2005) Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 76:194–202

    Article  PubMed  CAS  Google Scholar 

  27. Belachew DA, Sandu N, Schaller B, Guta Z (2009) Ankylosing spondylitis in sub-Saharan Africa. Postgrad Med J 85:353–357

    Article  PubMed  CAS  Google Scholar 

  28. Gofton JP, Robinson HS, Trueman GE (1966) Ankylosing spondylitis in a Canadian Indian population. Ann Rheum Dis 25:525–527

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of VIP health care Center, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China

    Benrong Zheng

  2. Department of Rheumatology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China

    Tianwang Li, Zhixiang Huang, Min Wang, Weiming Deng, Zetao Liao & Jieruo Gu

  3. Department of Oncology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China

    Qu Lin

Authors
  1. Benrong Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tianwang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qu Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhixiang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Min Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Weiming Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zetao Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jieruo Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tianwang Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zheng, B., Li, T., Lin, Q. et al. Prevalence of hepatitis B surface antigen in patients with ankylosing spondylitis and its association with HLA-B27: a retrospective study from south China. Rheumatol Int 32, 2011–2016 (2012). https://doi.org/10.1007/s00296-011-1934-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-1934-7

Keywords

Search

Navigation